These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37854600)

  • 1. Case Report: Successful treatment with methotrexate in a 10-year-old boy with co-occurrence of generalized psoriasis and vitiligo.
    Leong PY; Chiu TM; Wei JC; Huo AP
    Front Immunol; 2023; 14():1255909. PubMed ID: 37854600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of vitiligo and psoriasis: three case reports.
    Bakar-Dertlioğlu S; Uçak H; Ciçek D; Bitiren M
    Turk J Pediatr; 2012; 54(1):77-9. PubMed ID: 22397050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One stone, two birds: Improvement of early-onset vitiligo under apremilast in a patient with plaque psoriasis.
    Plachouri KM; Kyriakou G; Chourdakis V; Georgiou S; Grafanaki K
    Dermatol Ther; 2019 Sep; 32(5):e13064. PubMed ID: 31414705
    [No Abstract]   [Full Text] [Related]  

  • 4. Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?
    Ugurer E; Altunay IK; Erdem Y; Ozkur E; Tuncel D
    Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Colocalized Vitiligo and Psoriasis.
    Langley AR; Manley P; Asai Y
    J Cutan Med Surg; 2016; 20(2):150-2. PubMed ID: 26512071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent vitiligo and psoriasis.
    Karn D; Kc S
    Kathmandu Univ Med J (KUMJ); 2012; 10(37):83-4. PubMed ID: 22971869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection.
    Seçkin D; Durusoy C; Sahin S
    Pediatr Dermatol; 2004; 21(5):577-9. PubMed ID: 15461767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic CD4+T-cell lymphocytopenia associated with vitiligo.
    Yamauchi PS; Nguyen NQ; Grimes PE
    J Am Acad Dermatol; 2002 May; 46(5):779-82. PubMed ID: 12004324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK-inhibitors in dermatology: current evidence and future applications.
    Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L
    J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of psoriasis vulgaris, bullous pemphigoid and vitiligo: a case report.
    Pasić A; Ljubojević S; Lipozencić J; Marinović B; Loncarić D
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):426-7. PubMed ID: 12224717
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriasis superimposed on vitiligo: the tricolored vulva.
    Tin KS; Scurry J; Dyall-Smith D
    J Low Genit Tract Dis; 2014 Jan; 18(1):E1-3. PubMed ID: 24375029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice.
    Mazhar F; Krantz Å; Schalin L; Lysell J; Carrero JJ
    J Dermatolog Treat; 2023 Dec; 34(1):2215354. PubMed ID: 37246910
    [No Abstract]   [Full Text] [Related]  

  • 13. A patient with psoriasis and vitiligo treated with etanercept.
    Campanati A; Giuliodori K; Ganzetti G; Liberati G; Offidani AM
    Am J Clin Dermatol; 2010; 11 Suppl 1():46-8. PubMed ID: 20586509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.
    Otero ME; van den Reek JMPA; van de Kerkhof PCM; Mertens JS; Seyger MMB; Kievit W; de Jong EMGJ
    Acta Derm Venereol; 2019 Apr; 99(4):386-392. PubMed ID: 30543381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review.
    Dogra S; Sharma A; Mehta H; Sarkar R
    Clin Exp Dermatol; 2023 Sep; 48(10):1102-1112. PubMed ID: 37235767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management with efalizumab of a patient with psoriasis and comorbid vitiligo.
    Fernandez-Obregon AC
    J Drugs Dermatol; 2008 Jul; 7(7):679-81. PubMed ID: 18664161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
    Qi F; Liu F; Gao L
    Front Immunol; 2021; 12():790125. PubMed ID: 34868078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of vitiligo in a psoriasis patient on ixekizumab.
    Marasca C; Fornaro L; Martora F; Picone V; Fabbrocini G; Megna M
    Dermatol Ther; 2021 Sep; 34(5):e15102. PubMed ID: 34436817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Janus kinase inhibitors: A review of applications in dermatology.
    Hosking AM; Juhasz M; Mesinkovska NA
    J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies.
    Nguyen JK; Schlichte MJ; Jogi R; Alikhan M; Patel AB
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.